インドの血管アクセスデバイス市場：製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測、2019年～2033年

インドの血管アクセスデバイスの市場規模は、2026年～2033年の予測期間中に6.81％のCAGRで拡大し、2025年の4億7,993万米ドルから2033年には7億6,107万米ドルに成長すると予測されています。インドの血管アクセスデバイス市場は、長期的な血管アクセスを必要とする糖尿病やがんなどの生活習慣病が増加していることから、大きく成長しています。病院インフラへの政府投資とヘルスケアサービスへのアクセス向上が、機器の採用を加速させています。さらに、カテーテルの素材やデザインにおける技術革新は、安全性、効率性、患者の転帰を向上させ、ヘルスケア環境全体へのさらなる普及を促進しています。

例えば、AbbottはインドでUltreon 1.0ソフトウェアによる新しい血管画像プラットフォームの導入を宣言しました。人工知能（AI）と光干渉断層計（OCT）を使用した血管内イメージング・ソフトウェアは、医師に冠動脈の閉塞と血流を徹底的に理解させるものです。この最先端のイメージング・ソフトウェアは、血管の直径を評価し、カルシウムに基づく閉塞の程度を特定し、石灰化した閉塞とそうでない閉塞を自動的に区別することができます。冠動脈ステント留置術の精度を向上させるため、ステント留置の正確なガイドを行い、ステントの最適な拡張と留置を保証し、瞬時に結果を表示します。

当レポートでは、インドの血管アクセスデバイス市場について調査し、市場の概要とともに、製品タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 インドの血管アクセスデバイス市場の見通し、2019年～2033年

• 市場規模分析と予測
• 市場シェア分析と予測
• 2025年の市場マップ分析
  • 製品タイプ別
  • 用途別
  • エンドユーザー別
  • 地域別

第5章 バリューチェーン分析

第6章 需要供給分析

第7章 ポーターのファイブフォース分析

第8章 PESTLE分析

第9章 価格分析

第10章 市場力学

• 市場の促進要因
• 市場の課題

第11章 市場動向と発展

第12章 規制枠組みとイノベーション

第13章 競合情勢

• 市場リーダートップ5の競合マトリックス
• 参入企業トップ5のSWOT分析
• 市場の主要企業トップ10の情勢
  • BD India Pvt. Ltd.
  • Teleflex Medical Private Limited
  • Nipro Medical India Pvt. Ltd.
  • ICU Medical, Inc.
  • AngioDynamics, Inc.
  • Medtronic India Pvt. Ltd.
  • B. Braun Medical (India) Pvt. Ltd.
  • Terumo India Private Limited
  • Newtech Medical Devices Private Limited
  • Poly Medicure Ltd.

第14章 戦略的提言

第15章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Vascular Access Devices Market, By Value, In USD Million, FY2019-FY2033F
• Figure 2. India Vascular Access Devices Market, By Volume, In Million Units, FY2019-FY2033F
• Figure 3. India Vascular Access Devices Market Share (%), By Product Type, FY2019-FY2033F
• Figure 4. India Vascular Access Devices Market Share (%), By Application, FY2019-FY2033F
• Figure 5. India Vascular Access Devices Market Share (%), By End-user, FY2019-FY2033F
• Figure 6. India Vascular Access Devices Market Share (%), By Region, FY2019-FY2033F
• Figure 7. By Product Type Map-Market Size (USD Million) & Growth Rate (%), FY2025
• Figure 8. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2025
• Figure 9. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2025
• Figure 10. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2025

India vascular access devices market is projected to witness a CAGR of 6.81% during the forecast period FY2026-FY2033, growing from USD 479.93 million in FY2025 to USD 761.07 million in FY2033. India market for vascular access devices has grown significantly because of the rising prevalence of lifestyle-related diseases such as diabetes and cancer, which require long-term vascular access. Government investments in hospital infrastructure and improved access to healthcare services are accelerating device adoption. Additionally, innovation in catheter materials and design is enhancing safety, efficiency, and patient outcomes, promoting further uptake across healthcare settings.

For example, Abbott declared the introduction of their new vascular imaging platform in India, which is driven by Ultreon 1.0 software. Using artificial intelligence (AI) and optical coherence tomography (OCT), intravascular imaging software gives doctors a thorough understanding of coronary artery blockages and blood flow. The cutting-edge imaging software can assess vessel diameter, identify the degree of calcium-based blockages, and automatically distinguish between calcified and non-calcified blockages. In order to improve accuracy during coronary stenting procedures, it also assists doctors in guiding exact stent deployment, guaranteeing optimal stent expansion and apposition with instantaneous results presentation.

Growing Burden of Chronic and Infectious Diseases in India

India is witnessing a steep rise in the prevalence of chronic diseases such as cancer, chronic kidney disease, and cardiovascular ailments, along with infections requiring frequent hospitalizations. These conditions often demand long-term administration of medications, IV fluids, and blood transfusions, significantly increasing the demand for vascular access devices. Additionally, the increasing geriatric population, which is more susceptible to chronic conditions, has contributed to higher hospitalization and intravenous intervention rates. Moreover, the burden of infectious diseases like dengue and sepsis continues to require efficient diagnostic and treatment solutions, further supporting the need for secure vascular access. Government schemes such as Ayushman Bharat and expanded healthcare coverage are improving access to healthcare facilities, which in turn increases procedural volumes where vascular access devices are used. This broad healthcare push, combined with higher patient volumes and increasing disease burden, is driving consistent growth in the demand for vascular access devices across India. The burden of noncommunicable diseases (NCDs) has overtaken that of infectious diseases in India. An estimated 5.8 million Indians lose their lives to NCDs annually, and one in four Indians are at danger of passing away before turning 70. The World Health Organization (WHO) estimates that NCDs cause nine million deaths a year in Southeast Asia, or 62% of all deaths. The high rate of premature fatalities, or deaths that happen before the age of 70, associated with NCDs is a serious concern.

Rising Healthcare Infrastructure and Technological Advancements

India's healthcare infrastructure has seen massive development in recent years, with increasing numbers of public and private hospitals, specialty clinics, and diagnostic centers. These facilities are increasingly adopting advanced medical devices, including next-generation vascular access devices that offer safer insertions, longer dwell times, and improved infection control. Local manufacturing by Indian companies such as Poly Medicure and Newtech Medical Devices has led to the availability of cost-effective, technologically enhanced solutions that match global standards. Additionally, the "Make in India" initiative has catalyzed innovation and local production of vascular access devices, enhancing availability and affordability. Hospitals and surgical centers are becoming more equipped with imaging-guided insertion tools, antimicrobial-coated catheters, and closed IV systems to reduce complications. This rapid evolution in infrastructure, alongside the acceptance of new technologies in vascular access, is playing a pivotal role in strengthening the market across Tier 1 and Tier 2 cities in India. In August 2023, Poly Medicure Ltd., a major Indian vascular access device manufacturer, opened its 10th manufacturing facility in India to enhance its product offerings, including central venous catheters, PICCs, and other vascular access solutions, under the "Make in India" initiative. This expansion supports the local availability of advanced and affordable vascular access devices.

High Adoption of Central Vascular Access Devices in Critical Care

Central vascular access devices (CVADs) are witnessing increasing demand in India, especially in ICUs and oncology centers. Their ability to provide long-term venous access, administer large volumes of fluids, chemotherapeutics, and parenteral nutrition makes them critical for managing severely ill patients. In tertiary care hospitals, CVADs are preferred for hemodynamic monitoring and blood sampling in patients requiring prolonged treatment. Moreover, the rising number of organ transplants, dialysis cases, and cancer treatments are expanding their use. Central lines, such as peripherally inserted central catheters (PICCs), tunneled catheters, and implanted ports, are gaining traction due to their lower infection rates and enhanced patient comfort when used for long durations. The increasing awareness about catheter-associated bloodstream infections (CLABSIs) is also encouraging hospitals to adopt high-quality CVADs with antimicrobial coatings. This growing preference and usage in critical care and oncology settings are making central vascular access devices a key revenue-generating segment in the Indian market. In March 2024, AIIMS Delhi announced upgrades to its ICU facilities, including the adoption of new generation of antimicrobial-coated central venous catheters (CVCs) for critical care, aimed at reducing bloodstream infections. This is part of their infection control program and reflects a growing preference for central vascular access devices in tertiary and teaching hospitals.

Future Market Scenario (FY2026 - FY2033F)

The India vascular access devices market is expected to witness robust growth in the coming years, driven by increasing hospital admissions, a rising burden of chronic diseases, and expanding healthcare infrastructure. With growing awareness of infection control and a push for safer, more efficient intravenous access methods, demand for advanced vascular access technologies is projected to rise. Additionally, government initiatives to strengthen public healthcare facilities and the rise of private multispecialty hospitals are anticipated to support market expansion. Local manufacturing capabilities and technological collaborations may further enhance the domestic supply chain for these devices.

Key Players Landscape and Outlook

Key players in the vascular access devices industry utilize strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.

For instance, former L&T chairman AM Naik and seasoned businessman Madhusudan Kela are among the investors who have contributed approximately Rs 300 crore to S3V Vascular Technologies Limited, a medical device manufacturing company situated in Mysore.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India Vascular Access Devices Market Outlook, FY2019-FY2033F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product Type
    • 4.2.1.1. Central Vascular Access Device
    • 4.2.1.2. Peripheral Vascular Access Device
    • 4.2.1.3. Accessories
  • 4.2.2. By Application
    • 4.2.2.1. Drug Administration
    • 4.2.2.2. Fluid and Nutrition Administration
    • 4.2.2.3. Blood Transfusion
    • 4.2.2.4. Diagnostics
  • 4.2.3. By End-user
    • 4.2.3.1. Hospitals
    • 4.2.3.2. Clinics
    • 4.2.3.3. Ambulatory Surgical Centers
    • 4.2.3.4. Others
  • 4.2.4. By Region
    • 4.2.4.1. North
    • 4.2.4.2. East
    • 4.2.4.3. West and Central
    • 4.2.4.4. South
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2025)
• 4.3. Market Map Analysis, FY2025
  • 4.3.1. By Product Type
  • 4.3.2. By Application
  • 4.3.3. By End-user
  • 4.3.4. By Region

5. Value Chain Analysis

6. Demand Supply Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

• 10.1. Market Drivers
• 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Framework and Innovation

13. Competitive Landscape

• 13.1. Competition Matrix of Top 5 Market Leaders
• 13.2. SWOT Analysis for Top 5 Players
• 13.3. Key Players Landscape for Top 10 Market Players
  • 13.3.1. BD India Pvt. Ltd.
    • 13.3.1.1. Company Details
    • 13.3.1.2. Key Management Personnel
    • 13.3.1.3. Products and Services
    • 13.3.1.4. Financials (As Reported)
    • 13.3.1.5. Key Market Focus and Geographical Presence
    • 13.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 13.3.2. Teleflex Medical Private Limited
  • 13.3.3. Nipro Medical India Pvt. Ltd.
  • 13.3.4. ICU Medical, Inc.
  • 13.3.5. AngioDynamics, Inc.
  • 13.3.6. Medtronic India Pvt. Ltd.
  • 13.3.7. B. Braun Medical (India) Pvt. Ltd.
  • 13.3.8. Terumo India Private Limited
  • 13.3.9. Newtech Medical Devices Private Limited
  • 13.3.10. Poly Medicure Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us and Disclaimer